Acasti Pharma, Inc. (ACST)

Acasti Pharma (ACST) Stock Price & Analysis


ACST Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.34 - $1.35
Previous Close$0.43
Average Volume (3M)124.55K
Market Cap
Enterprise Value-$11.52M
Total Cash (Recent Filing)$31.26M
Total Debt (Recent Filing)$503.00K
Price to Earnings (P/E)-1.1
Jun 28, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding44,612,831
10 Day Avg. Volume39,590
30 Day Avg. Volume124,545
Standard Deviation0.36
Financial Highlights & Ratios
Price to Book (P/B)1.34
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.63
Price Target Upside479.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Acasti Pharma, Inc.’s price range in the past 12 months?
Acasti Pharma, Inc. lowest stock price was $0.34 and its highest was $1.35 in the past 12 months.
    What is Acasti Pharma, Inc.’s market cap?
    Currently, no data Available
    When is Acasti Pharma, Inc.’s upcoming earnings report date?
    Acasti Pharma, Inc.’s upcoming earnings report date is Jun 28, 2023 which is in 91 days.
      How were Acasti Pharma, Inc.’s earnings last quarter?
      Acasti Pharma, Inc. released its earnings results on Feb 14, 2023. The company reported -$0.09 earnings per share for the quarter, beating the consensus estimate of -$0.123 by $0.033.
        Is Acasti Pharma, Inc. overvalued?
        According to Wall Street analysts Acasti Pharma, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Acasti Pharma, Inc. pay dividends?
          Acasti Pharma, Inc. does not currently pay dividends.
          What is Acasti Pharma, Inc.’s EPS estimate?
          Acasti Pharma, Inc.’s EPS estimate is -$0.12.
            How many shares outstanding does Acasti Pharma, Inc. have?
            Acasti Pharma, Inc. has 44,612,830 shares outstanding.
              What happened to Acasti Pharma, Inc.’s price movement after its last earnings report?
              Acasti Pharma, Inc. reported an EPS of -$0.09 in its last earnings report, beating expectations of -$0.123. Following the earnings report the stock price went up 3.125%.
                Which hedge fund is a major shareholder of Acasti Pharma, Inc.?
                Currently, no hedge funds are holding shares in ACST


                Acasti Pharma Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Acasti Pharma, Inc.

                Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.


                Top 5 ETFs holding ACST

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold ACST. The ETFs are listed according to market value of ACST within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Core One Labs
                Heritage Cannabis Holdings Corp
                Allied (California)

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis